Myomo Inc MYO under CEO Paul Gudonis
March 21, 2024 by
Mannatech Inc MTEX under CEO Alfredo Bala
March 21, 2024 by
Gritstone bio Inc GRTS under CEO Andrew Allen
March 21, 2024 by
Marketaxess Holdings Inc MKTX under CEO Christopher Concannon
March 18, 2024 by
AN2 Therapeutics Inc ANTX under CEO Eric Easom
March 18, 2024 by
Thermogenesis Holdings Inc THMO under CEO Xiaochun Xu
March 18, 2024 by
NRX Pharmaceuticals Inc NRXP under CEO Stephen Willard
March 18, 2024 by